Vizgen debuts accelerator lab in the U.S.

By The Science Advisory Board staff writers

January 6, 2021 -- Life sciences company Vizgen has established an accelerator lab in the U.S. to advance pharmaceutical research and development.

The pharma accelerator lab was launched to meet the high demand from pharmaceutical companies who continue to turn to single-cell and spatial transcriptomics technology to speed up drug development pipelines.

Additionally, Vizgen began an early release program so scientific investigators could gain access to its multiplexed error-robust fluorescence in situ hybridization (MERFISH) platform ahead of its commercial launch.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.